Drawing for NIGHT FEVER

USPTO serial 79154858

NIGHT FEVER

Reviewed by CopyMark Law Group

Reg. 4834034Status 709
Filing date
Status date
Registration date
Oct 20, 2015
Examiner
BUTTON, JENNIFER JO
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NIGHT FEVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Margaret L. O'Donnell

Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for enhancing energy production in the body, parapharmaceutical preparations for enhancing energy production in the body, dietetic foods adapted for medical and paramedical use, namely, pasta and crackers, as well as dietary food supplements for medical or paramedical use, each of which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; pharmaceutical and parapharmaceutical preparations for enhancing energy production, all made from plants, extracts of plants, or vegetable extracts and available in effervescent or other forms; pharmaceutical and parapharmaceutical preparations for use as a treatment for enhancing energy production, all containing minerals or vitamins, and available in effervescent or other forms; vitamins and mineral supplements in effervescent or other forms; pharmaceutical and parapharmaceutical preparations, based on phytotherapy and for enhancing energy production; nutritional supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use, as additions to the nutrient intake in a normal diet, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; all dietetic foods supplements adapted for medical and paramedical use, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; nutritional supplements for medical use prepared for human consumption from food ingredients of vegetable or mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable or mineral origin, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; fortifying nutritional food supplements adapted for medical use; fortifying nutritional food supplements adapted for paramedical use, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredientsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026RNWLINTERNATIONAL REGISTRATION RENEWED
Jul 2, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 6, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 11, 2022RFNTREFUSAL PROCESSED BY IB
May 6, 2022C71TCANCELLED SECTION 71
Oct 20, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 2, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2016RNWLINTERNATIONAL REGISTRATION RENEWED
Apr 1, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2016FIMPFINAL DISPOSITION PROCESSED
Jan 20, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 28, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
Aug 4, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 21, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2015ALIEASSIGNED TO LIE
Jun 8, 2015ALIEASSIGNED TO LIE
Jun 1, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 26, 2014RFNTREFUSAL PROCESSED BY IB
Dec 3, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 3, 2014RFRRREFUSAL PROCESSED BY MPU
Dec 3, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 2, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2014DOCKASSIGNED TO EXAMINER
Nov 22, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Nov 18, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 13, 2014SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance